Group One Trading’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-42,327
| Closed | -$3.93M | – | 9116 |
|
|
2021
Q4 | $3.93M | Buy |
42,327
+40,079
| +1,783% | +$2.64M | ﹤0.01% | 1922 |
|
|
2021
Q3 | $134K | Buy |
+2,248
| New | +$133K | ﹤0.01% | 5609 |
|
|
2021
Q2 | – | Sell |
-7,339
| Closed | -$478K | – | 8781 |
|
|
2021
Q1 | $509K | Buy |
+7,339
| New | +$565K | ﹤0.01% | 4017 |
|
|
2019
Q1 | – | Sell |
-55,092
| Closed | -$2.53M | – | 5584 |
|
|
2018
Q4 | $2.15M | Sell |
55,092
-40,088
| -42% | -$1.57M | 0.02% | 992 |
|
|
2018
Q3 | $4.38M | Buy |
95,180
+19,303
| +25% | +$782K | 0.03% | 659 |
|
|
2018
Q2 | $3.31M | Sell |
75,877
-8,493
| -10% | -$365K | 0.03% | 770 |
|
|
2018
Q1 | $3.33M | Sell |
84,370
-41,915
| -33% | -$1.63M | 0.03% | 681 |
|
|
2017
Q4 | $4.29M | Buy |
126,285
+9,593
| +8% | +$273K | 0.03% | 719 |
|
|
2017
Q3 | $2.98M | Buy |
116,692
+47,305
| +68% | +$1.08M | 0.03% | 807 |
|
|
2017
Q2 | $1.17M | Buy |
69,387
+34,813
| +101% | +$477K | 0.01% | 1325 |
|
|
2017
Q1 | $505K | Sell |
34,574
-17,081
| -33% | -$253K | 0.01% | 1846 |
|
|
2016
Q4 | $734K | Sell |
51,655
-7,640
| -13% | -$118K | 0.01% | 1528 |
|
|
2016
Q3 | $1.04M | Buy |
59,295
+1,492
| +3% | +$24.7K | 0.01% | 1264 |
|
|
2016
Q2 | $988K | Sell |
57,803
-4,734
| -8% | -$84.6K | 0.01% | 1269 |
|
|
2016
Q1 | $1.23M | Sell |
62,537
-26,929
| -30% | -$432K | 0.02% | 1036 |
|
|
2015
Q4 | $1.7M | Buy |
89,466
+20
| +0% | +$408 | 0.02% | 971 |
|
|
2015
Q3 | $1.71M | Sell |
89,446
-13,431
| -13% | -$456K | 0.02% | 890 |
|
|
2015
Q2 | $4.77M | Buy |
102,877
+6,278
| +6% | +$272K | 0.07% | 348 |
|
|
2015
Q1 | $4.22M | Sell |
96,599
-65,557
| -40% | -$3.05M | 0.07% | 306 |
|
|
2014
Q4 | $5.63M | Buy |
162,156
+7,800
| +5% | +$317K | 0.08% | 247 |
|
|
2014
Q3 | $6.47M | Buy |
154,356
+73,994
| +92% | +$3.3M | 0.1% | 214 |
|
|
2014
Q2 | $4.71M | Buy |
80,362
+68,856
| +598% | +$4.34M | 0.07% | 320 |
|
|
2014
Q1 | $725K | Buy |
+11,506
| New | +$763K | 0.01% | 1342 |
|
|
2013
Q4 | – | Sell |
-29,889
| Closed | -$1.57M | – | 5645 |
|
|
2013
Q3 | $1.57M | Buy |
+29,889
| New | +$2.01M | 0.03% | 698 |
|
Group One Trading's ARNA Position: Q1 2022 in Review
Group One Trading sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 42,327 shares — an estimated $3.93M sold.
Group One Trading first reported a position in ARNA in Q3 2013 and held it in 24 quarters. The position peaked at $6.47M in Q3 2014. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Group One Trading reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Group One Trading sold 42,327 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $3.93M.
- Group One Trading first reported a position in Arena Pharmaceuticals Inc in Q3 2013 and held it in 24 quarters.
- Group One Trading's Arena Pharmaceuticals Inc position peaked at $6.47M in Q3 2014.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Group One Trading's 13F filing for Q1 2022, filed 12 May 2022.